Centene
About: Centene is a managed care organization that focuses on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 22 million medical members as of December 2024, mostly in Medicaid (about 60% of membership), the individual exchanges (about 20%), and Medicare (about 5%). The company also has a military contract and provides Medicare Part D pharmaceutical plans.
Employees: 60,500
Fund manager confidence
Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)
39% more first-time investments, than exits
New positions opened: 121 | Existing positions closed: 87
2% more funds holding
Funds holding: 860 [Q4 2024] → 876 (+16) [Q1 2025]
0% more funds holding in top 10
Funds holding in top 10: 12 [Q4 2024] → 12 (+0) [Q1 2025]
1% less repeat investments, than reductions
Existing positions increased: 320 | Existing positions reduced: 322
5% less capital invested
Capital invested by funds: $29.1B [Q4 2024] → $27.7B (-$1.36B) [Q1 2025]
2.86% less ownership
Funds ownership: 95.01% [Q4 2024] → 92.15% (-2.86%) [Q1 2025]
35% less call options, than puts
Call options by funds: $183M | Put options by funds: $281M
Research analyst outlook
4 Wall Street Analysts provided 1 year price targets over the past 3 months
4 analyst ratings
Morgan Stanley Ricky Goldwasser | 27%upside $70 | Overweight Initiated | 9 Jun 2025 |
Barclays Andrew Mok | 18%upside $65 | Equal-Weight Downgraded | 2 Jun 2025 |
Jefferies David Windley | 10%upside $61 | Hold Maintained | 29 Apr 2025 |
Baird Michael Ha | 25%upside $69 | Neutral Maintained | 15 Apr 2025 |
Financial journalist opinion
Based on 14 articles about CNC published over the past 30 days









